Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 2/20 | 0.31 |
| ▸ | RAC2 | P15153 | 1/20 | 0.30 |
| ▸ | RAC3 | P60763 | 1/20 | 0.30 |
| ▸ | CDC42 | P60953 | 1/20 | 0.30 |
| ▸ | RAC1 | P63000 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23911697 | 0.83 | NPSR1 (0.31) | — | |
| SCHEMBL23911716 | 0.82 | — | — | |
| SCHEMBL23911720 | 0.80 | — | — | |
| SCHEMBL23911727 | 0.79 | KDM4E (0.46) | RAC2RAC3CDC42RAC1 | |
| SCHEMBL18056702 | 0.78 | GPR3 (0.47) | — | |
| SCHEMBL23911721 | 0.77 | TSPO (0.32) | — | |
| SCHEMBL23431270 | 0.77 | LMNA (0.33) | — | |
| SCHEMBL12792049 | 0.75 | NPSR1 (0.40) | — | |
| SCHEMBL23431347 | 0.75 | NPSR1 (0.44) | — | |
| SCHEMBL6123861 | 0.74 | L3MBTL1 (0.43) | P2RX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220020937-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-01-20 | — | — | US | disclosed |
| US-11145823-B2 | Heterocyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11145823-B2 | Heterocyclic compound and organic light emitting device including the same | TRPC1, ODC1, DDT | P2RX4 905/4885RAC2 3460/4885RAC3 4169/4885 |
| US-20220020937-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | TRPC1, ODC1, DDT | P2RX4 943/4885RAC2 3199/4885RAC3 3945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.